In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senator drafts US bill aimed at safeguarding supply chain, but lacking inspection fees

This article was originally published in Scrip

Executive Summary

Congress may be preparing for the August recess, but US Senator Michael Bennet (Democrat, Colorado), has decided that it would be a good time to introduce a bill providing the FDA with mandatory recall authority and greater oversight of manufacturing quality for both foreign and domestic companies so that lawmakers could consider the issues when they reconvene. In tackling such a debated issue as how to oversee a pharmaceutical supply chain that has become globalised, Bennet's bill faces an uncertain future; it will now be referred to a health committee.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC009799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel